Revised SPC: Humulin (human insulin) products

SPCs now advise that patients must be instructed to perform continuous rotation of the injection site to reduce the risk of developing lipodystrophy and cutaneous amyloidosis, which can lead to potential risk of delayed insulin absorption and worsened glycaemic control.

Source:

electronic Medicines compendium